Hai Liu

Hai Liu

Auto-generated profile, based on publicly available information

Hai Liu

Department of Sports Medicine, Meizhou People's Hospital, Meizhou Academy of Medical Sciences, Meizhou, Guangdong, 514031, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 March 2021 in Journal of Tissue Engineering and Regenerative Medicine
Verified
Journal Article
Closed access
PDF file
HLHai Liu
Hai Liu
HZHuangrong Zhu
Huangrong Zhu
LCLiang Cheng
Liang Cheng
YZYitao Zhao
Yitao Zhao
XCXizhong Chen
Xizhong Chen
DCDaozhang Cai
Daozhang Cai

26 August 2025 in Materials Today Bio
Verified
Journal Article
Open access
HLHai Liu
Hai Liu
SLSonglang Liu
Songlang Liu
LLLiqiong Liao
Liqiong Liao
HLHongxing Liao
Hongxing Liao
WPWeilun Pan
Weilun Pan
JHJun Hu
Jun Hu
Combining disinfection and bone regeneration in a one-step treatment is of significant clinical importance for chronic osteomyelitis, yet it remains a considerable challenge. To address this, we developed a dual stimulus-responsive decellularized extracellular matrix (dECM) cryogel (GC-dECM@CPN). The cryogel is composed of methacrylate gelatin (GelMA), carboxymethyl chitosan (CMCS), dECM, and temperature-sensitive phase-transition copper peroxide nanoparticles (CPNs). During the infection phase of chronic osteomyelitis, the cryogel exhibits a strong photothermal conversion efficiency under near-infrared (NIR) light irradiation, triggering the release of CPNs to perform chemodynamic therapy (CDT) in the acidic, infected environment. This process enhances macrophage polarization toward the M1 phenotype, promoting the phagocytosis of residual bacteria. Following bacterial eradication, the dECM within the cryogel facilitates the differentiation of bone marrow mesenchymal stem cells (BMSCs) into osteoblasts while reprogramming macrophages into the M2 phenotype, thereby establishing a conducive environment for bone regeneration. The GC-dECM@CPN cryogel exhibited desirable therapeutic efficacy in both in vitro and in vivo studies, with critical stages of chronic osteomyelitis—including early infection, initial bone regeneration, and recovery—investigated and discussed in detail. This study introduces an innovative dual stimulus-responsive dECM cryogel that effectively treats chronic osteomyelitis through a one-step surgical approach, offering valuable insights for clinical therapeutic strategies in this field.

13 May 2026 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
HLHai Liu
Hai Liu
LZLulong Zhao
Lulong Zhao
WPWeilun Pan
Weilun Pan
SLSonglang Liu
Songlang Liu
HLHongxing Liao
Hongxing Liao
LLLiqiong Liao
Liqiong Liao
Guidance of photo-tunable dynamic stiffening hydrogel on the differentiation fate of BMSCs in vitro and application in calvarial defect regeneration in vivo .

26 June 2023 in Research Square
Verified
Preprint
Open access
PDF file
HLHai Liu
Hai Liu
WPWeilun Pan
Weilun Pan
HLHai Liu
Hai Liu
DXDenghui Xie
Denghui Xie
LLLiqiong Liao
Liqiong Liao
Background Osteoporosis is a systemic bone disease prone to fractures due to decreased bone density and bone quality. The pathological environment of osteoporosis interferes with the normal process of fracture healing. The clinical regenerative repair materials specifically used for osteoporotic bone defects are not satisfactory, and the study of the mechanism of bone defect regeneration in the pathological environment of osteoporosis is helpful for the design of related materials.Methods In this study, the cryogels were prepared from decellularized extracellular matrix (dECM), methacrylate gelatin (GelMA), and carboxymethyl chitosan (CMCS) via unidirectional freezing, photocrosslinking, and genipin crosslinking. dECM extracted from normal or osteoporotic rats was applied for the preparation of the cryogels, named as GelMA-CMCS@Normal or GelMA-CMCS@OVX, respectively. The effects of different cryogels on BMSCs isolated from osteoporotic rats (OVX-BMSCs) were observed in vitro and in vivo.Results It was verified that the cryogels had excellent in vitro and in vivo biocompatibility. Furthermore, the GelMA-CMCS@Normal could effectively improve the proliferation of OVX-BMSCs, and promote the differentiation of OVX-BMSCs into osteoblasts in vitro and in vivo. RNA sequencing found that the OVX-BMSCs co-cultured with GelMA-CMCS@Normal cryogel exhibited down-regulated expression of reactive oxygen species modulator 1 (Romo1), which could activate the expression of nuclear factor erythroid 2-related factor 2 (Nfe2l2, NRF2). Further evidence showed that the reactive oxygen species (ROS) of the OVX-BMSCs were scavenged effectively after co-cultured with the GelMA-CMCS@Normal cryogel.Conclusions The results indicated that GelMA-CMCS@Normal cryogel was expected to be a clinical candidate for the repair of osteoporotic bone defects by regulating the ROS niche of OVX-BMSCs.Trial registration: Not applicable.